Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform
"Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform." Presented by Matthew Lotti, Sr. Research Associate II, Analytical Development Team, Ultragenyx Pharmaceutical.
BioProcess International Ask the Expert 2021.
Видео Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform канала BioProcess International
BioProcess International Ask the Expert 2021.
Видео Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform канала BioProcess International
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![PANEL DISCUSSION Emerging Bio Therapies and Their Manufacturing Challenges](https://i.ytimg.com/vi/WMB8yNmf3-c/default.jpg)
![Strategies for Implementing New Technologies in an Outsourcing Environment: A Roundtable Discussion](https://i.ytimg.com/vi/DPtAm2hljZI/default.jpg)
![Reducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody...](https://i.ytimg.com/vi/QTt2jtj9P24/default.jpg)
![Aseptic Filling for Gene Therapies and Next Generation Biologics Within Closed Robotic Workcells](https://i.ytimg.com/vi/IDUdIeP7F3Q/default.jpg)
![CRISPR Library Screens for Oncology Target Discovery](https://i.ytimg.com/vi/XPR0zEc6Zsk/default.jpg)
![Evaluation of the "Scale-Out" Biomanufacturing Strategy from Early Clinical...](https://i.ytimg.com/vi/JbX8vwDW4Y4/default.jpg)
![Exploring New and Improved Analytical Methods for Traditional and Unique Modalities](https://i.ytimg.com/vi/PAnaFjRivYE/default.jpg)
![Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing](https://i.ytimg.com/vi/2talI5XaWmM/default.jpg)
![Practical Approaches to Metals Analysis of Cell Culture Media](https://i.ytimg.com/vi/-mSCW3R1yC4/default.jpg)
![The Critical Steps for Protein Therapeutic Potency Assay Development](https://i.ytimg.com/vi/9OtgmS-NeN4/default.jpg)
![Downstream Processing with Giorgio Carta](https://i.ytimg.com/vi/e3iA0pTEig4/default.jpg)
![China's GMP Strategies: Dealing with Quality Management Issues, to Compete with the West](https://i.ytimg.com/vi/2J-YBIOR4eU/default.jpg)
![How to Halve the Costs of Antibody Purification?](https://i.ytimg.com/vi/6bSmZ9Y3wC8/default.jpg)
![Transform Cell Expansion: Expand Outside the Hood](https://i.ytimg.com/vi/9-ePgm4hYQc/default.jpg)
![Translating Inhaled and Nasal Technologies for the Delivery of Biologics](https://i.ytimg.com/vi/FMoeiNzlAh0/default.jpg)
![Advantages of Fluoropolymer Single-Use Systems](https://i.ytimg.com/vi/xId5GTthFjk/default.jpg)
![Securing Your Manufacturing Capacity During a Pandemic](https://i.ytimg.com/vi/LajKp5OeK7Q/default.jpg)
![Bioconjugation CMC: Successfully Executing a Complex Process](https://i.ytimg.com/vi/fNRKoOEtgLE/default.jpg)
![BPI Theater @ BIO 2016 Comprehensive Hands On Training for Biopharmaceutical Manufacturing](https://i.ytimg.com/vi/j9O8y4_ITmk/default.jpg)
![Gene Therapy Product Analytics: Where Historical and Modern Techniques Meet](https://i.ytimg.com/vi/tnxcAKMICRM/default.jpg)
![Identification of Host Cell Protein (HCP) Impurities using Antibody Affinity Extraction....](https://i.ytimg.com/vi/v5_fbfIRCFY/default.jpg)